 
        The use of zolpidem for outpatient ACL reconstruction reduces narcotic consumption
 
                                                    The use of zolpidem for outpatient ACL reconstruction reduces narcotic consumption
The use of a non-benzodiazepine hypnotic sleep-aid (Zolpidem) in patients undergoing ACL reconstruction: a randomized controlled clinical trial
Knee Surg Sports Traumatol Arthrosc. 2011 May;19(5):787-91. doi: 10.1007/s00167-010-1368-x. Epub 2011 Jan 21Synopsis
29 patients were randomized to assess the effect of a non-benzodiazepine hypnotic sleep-aid, Zolpidem, on postoperative narcotic requirements, pain, and fatigue in patients undergoing outpatient anterior cruciate ligament (ACL) reconstruction. Patients received either a single dose of Zolpidem or a gelatin capsule (placebo) for the first seven postoperative nights. Results indicated that Zolpidem ...
                To view the full content, login to your account,
or start your 30-day FREE Trial today.
            
            FREE TRIAL
            LOGIN
            Forgot Password?
    Explore some of our unlocked ACE Reports below!
 
                Learn about our AI Driven 
 High Impact Search Feature
     
    Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue 
                     
                 
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         LOGIN
                                    LOGIN
                                 
            
Join the Conversation
Please Login or Join to leave comments.